HAI report reveals poor drug availability in Kyrgyzstan
This article was originally published in Scrip
Many medical treatments, even with cheap generic products, are unaffordable for patients in Kyrgyzstan, where around half the population lives below the poverty line, says a recent report from Health Action International (HAI), the non-profit independent network of more than 200 members, including consumer groups, healthcare providers and researchers in more than 70 countries.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.